| Grant revenue | |
| Royalty revenue | |
| Total Revenue | 38.53M |
| Research and development | 1.04M |
| General and administration | |
| Depreciation and amortization | 5.97M |
| Total Expenses | 30.6M |
| Convertible note fair value adjustment | |
| Interest expense | |
| Other income | |
| Interest income | |
| NET LOSS | |
| BASIC NET LOSS PER SHARE (in dollars per share) | 0.22 |
| DILUTED NET LOSS PER SHARE (in dollars per share) | 0.22 |
| WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in shares) | 11.47M |